867166-73-2 Usage
Uses
Used in Organic Synthesis:
1-(4-Nitrophenyl)piperazin-2-one is used as a building block for constructing various organic molecules due to its unique chemical properties conferred by the nitro group.
Used in Pharmaceutical Research:
1-(4-Nitrophenyl)piperazin-2-one is used as a precursor for developing new pharmaceutical drugs, as its structural features make it a potential candidate for further research into its biological and pharmacological properties.
Used in Drug Development:
1-(4-Nitrophenyl)piperazin-2-one is used in drug development to explore its potential as a therapeutic agent, given its unique chemical properties and structural features that may contribute to its biological activity.
Used in Organic Synthesis Research:
1-(4-Nitrophenyl)piperazin-2-one is used in organic synthesis research to study its reactivity and potential applications in the synthesis of diverse chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 867166-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,1,6 and 6 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 867166-73:
(8*8)+(7*6)+(6*7)+(5*1)+(4*6)+(3*6)+(2*7)+(1*3)=212
212 % 10 = 2
So 867166-73-2 is a valid CAS Registry Number.
867166-73-2Relevant academic research and scientific papers
PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
-
, (2022/02/24)
Disclosed in the present invention are a pyridazine-3-formamide compound suitable for inhibiting or regulating the Janus kinase (JAK), in particular tyrosine kinase 2 (TYK2), and a preparation method therefor and the medical use thereof. In particular, disclosed in the present invention are a compound as represented by general formula (I) and a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof, a method for treating and/or preventing Janus kinase-mediated related diseases, in particular autoimmune diseases, inflammatory diseases and cancers, by means of using the compound or the pharmaceutically acceptable salt thereof, and a method for preparing the compound or the pharmaceutically acceptable salt thereof. Each substituent of general formula (I) has the same definition as that in the description.
